CVS
36
3
DVA
56
2
SCHW
45
2
CCL
46
-4
IR
44
4
CMI
52
3
MCO
71
4
PPL
49
2
EXC
64
4
EXR
30
6
AAL
41
-4
WMB
62
2
HCP
52
7
XEL
50
-3
NEE
46
4
TRV
42
3
MAC
53
5
PAYX
38
2
ISRG
64
3
UA
53
3
CVS
36
3
DVA
56
2
SCHW
45
2
CCL
46
-4
IR
44
4
CMI
52
3
MCO
71
4
PPL
49
2
EXC
64
4
EXR
30
6
AAL
41
-4
WMB
62
2
HCP
52
7
XEL
50
-3
NEE
46
4
TRV
42
3
MAC
53
5
PAYX
38
2
ISRG
64
3
UA
53
3
Financhill
Back

Acrivon Therapeutics Stock Predictions

Hidden Stock Under $5 Holds Tech World Hostage

Click here to see more.
Sell
37

ACRV
Acrivon Therapeutics

Last Price:
$6.60
Seasonality Move:
28.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Caught Trading Under Secret Name...

Find out more about the "hidden stock" here.

Acrivon Therapeutics Stock Forecast

  • Over the next 52 weeks, Acrivon Therapeutics has on average historically fallen by 17.5% based on the past 2 years of stock performance.
  • Acrivon Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Acrivon Therapeutics Stock Undervalued?
    The current Acrivon Therapeutics [ACRV] share price is $6.62. The Score for ACRV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ACRV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Acrivon Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Acrivon Therapeutics has on average historically fallen by 17.5% based on the past 2 years of stock performance.

Acrivon Therapeutics Stock Rating

Sell
37
Acrivon Therapeutics (ACRV) is a Sell

Is Acrivon Therapeutics overpriced?

  • Acrivon Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Acrivon Therapeutics Stock Price History

Is ACRV stock going to rise?

  • The current trend is relatively stagnant and ACRV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
acrivon.com

52-Week Data

52-Week High:
11.90
52-Week Low:
3.19

Prediction Charts

Market Cap:
206.1M
Price in USD:
6.62
Volume:
70K
Beta:
0.77

Technical Analysis

SMA50:
7.19
SMA100:
7.57
SMA200:
7.67
52-Wk Change:
32.93%

Stock Predictions

  • Is Acrivon Therapeutics stock public?
    Yes, Acrivon Therapeutics is a publicly traded company.
  • What is the Acrivon Therapeutics stock quote today?
    The Acrivon Therapeutics stock price is 6.62 USD today.
  • How to buy Acrivon Therapeutics stock online?
    You can buy Acrivon Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 7.12 7.06 7.47 7.01
Dec-16 6.91 7.00 7.19 6.80
Dec-17 7.01 7.21 7.28 6.99
Dec-18 7.18 6.74 7.45 6.56
Dec-19 6.73 6.69 6.86 6.66
Dec-20 6.62 6.81 7.18 6.51
Dec-23 6.75 6.36 6.75 6.24
Dec-24 6.25 6.23 6.26 6.01
Dec-26 6.23 6.19 6.32 6.13
Dec-27 6.29 5.92 6.39 5.81
Dec-30 5.87 5.41 5.87 5.40
Dec-31 5.50 6.02 6.15 5.50
Jan-2 6.21 5.69 6.40 5.68
Jan-3 5.75 6.62 6.70 5.75

Acrivon Therapeutics Earnings

Acrivon Therapeutics Earnings Report: Per Share Acrivon Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Acrivon Therapeutics Forecast Revenue Growth

Acrivon Therapeutics Stock Analysis: Historical quarterly revenues per share for Acrivon Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.24 per share.

* Acrivon Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.